Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

3.0K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.0K
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

47
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
47
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

62
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
62
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

101
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
101
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

64
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
64
Angina II: Classification01:27

Angina II: Classification

49
Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
49

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Intelligence level and structure in school age children with fetal growth restriction].

Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics·2009
Same author

Uncoupling the D1-N-methyl-D-aspartate (NMDA) receptor complex promotes NMDA-dependent long-term potentiation and working memory.

Biological psychiatry·2009
Same author

A phospho-directed macroporous alumina-silica nanoreactor with multi-functions.

ACS nano·2009
Same author

Subintimal angioplasty for below-the-ankle arterial occlusions in diabetic patients with chronic critical limb ischemia.

Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists·2009
Same author

Natural killer/T cell lymphoma initiating with pleural effusion: the significance of MICM combined techniques for the diagnosis.

Zhongguo shi yan xue ye xue za zhi·2009
Same author

[Advance of study on animal models of lymphoma].

Zhongguo shi yan xue ye xue za zhi·2009

Related Experiment Video

Updated: Sep 28, 2025

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

5.4K

Study on Correlation between Type 2 Diabetes and No-Reflow after PCI.

Su-Rui Zhao1, Rui Huang2, Fang Liu2

  • 1Department of Cardiology IV, Cangzhou Central Hospital, Cangzhou, 061001 Hebei Province, China.

Disease Markers
|March 28, 2022
PubMed
Summary

Diabetic patients undergoing percutaneous coronary intervention (PCI) face a higher no-reflow risk. Longer diabetes duration and higher blood glucose levels correlate with increased no-reflow after PCI in these patients.

More Related Videos

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

5.3K
Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
07:25

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

Published on: September 22, 2020

3.5K

Related Experiment Videos

Last Updated: Sep 28, 2025

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

5.4K
Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

5.3K
Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
07:25

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

Published on: September 22, 2020

3.5K

Area of Science:

  • Cardiology
  • Endocrinology
  • Medical Research

Background:

  • Diabetes mellitus is a global chronic disease frequently complicated by cardiovascular diseases.
  • Percutaneous coronary intervention (PCI) is a primary treatment for cardiovascular complications in diabetic patients.
  • Diabetic patients exhibit a 2-4 times higher incidence of no-reflow after PCI compared to non-diabetic individuals, with unclear underlying mechanisms.

Purpose of the Study:

  • To investigate the relationship between diabetes duration, preoperative blood glucose levels, coronary angiographic blood flow, coronary artery stenosis, and the occurrence of no-reflow post-PCI.
  • To identify key predictors of no-reflow in diabetic patients undergoing PCI.

Main Methods:

  • A cohort of 131 type 2 diabetes patients undergoing PCI between 2019-2020 was divided into control and observation groups.
  • Data collected included diabetes duration, preoperative blood glucose levels, Thrombolysis In Myocardial Infarction (TIMI) flow, and coronary artery stenosis degree.
  • Binary logistic stepwise regression analysis was employed to determine correlations with no-reflow post-PCI.

Main Results:

  • Significant differences were observed in diabetes duration, blood glucose levels, TIMI values, and coronary stenosis between the groups.
  • Higher preoperative blood glucose levels (5.8% vs. 3.8%) and greater coronary stenosis (76% vs. 63%) were noted in the observation group.
  • Diabetes duration, elevated preoperative blood glucose, poorer coronary angiographic blood flow, and degree of coronary artery stenosis were positively associated with no-reflow after PCI.

Conclusions:

  • Diabetes duration and preoperative blood glucose levels are significant factors associated with no-reflow after PCI in diabetic patients.
  • Coronary angiographic blood flow and the extent of coronary artery stenosis also correlate positively with the risk of no-reflow.
  • These findings highlight the importance of glycemic control and assessing coronary status in diabetic patients undergoing PCI to mitigate no-reflow complications.